Bridgeway Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-112,000
| Closed | -$19.6K | – | 1435 |
|
|
2023
Q3 | $19.6K | Hold |
112,000
| – | – | ﹤0.01% | 1342 |
|
|
2023
Q2 | $349K | Buy |
112,000
+25,000
| +29% | +$78K | 0.01% | 1004 |
|
|
2023
Q1 | $223K | Sell |
87,000
-100,000
| -53% | -$256K | 0.01% | 1085 |
|
|
2022
Q4 | $279K | Hold |
187,000
| – | – | 0.01% | 1006 |
|
|
2022
Q3 | $325K | Hold |
187,000
| – | – | 0.01% | 1014 |
|
|
2022
Q2 | $243K | Buy |
187,000
+40,000
| +27% | +$52K | 0.01% | 1050 |
|
|
2022
Q1 | $350K | Buy |
147,000
+100,000
| +213% | +$238K | 0.01% | 1030 |
|
|
2021
Q4 | $216K | Sell |
47,000
-66,800
| -59% | -$307K | ﹤0.01% | 1153 |
|
|
2021
Q3 | $922K | Buy |
113,800
+3,800
| +3% | +$30.8K | 0.02% | 850 |
|
|
2021
Q2 | $1.08M | Buy |
110,000
+20,000
| +22% | +$197K | 0.02% | 833 |
|
|
2021
Q1 | $794K | Buy |
+90,000
| New | +$794K | 0.01% | 944 |
|